4-(4-{[4-(2-Chlorophenyl)piperazin-1-yl]carbonyl}piperidin-1-yl)[1]benzofuro[3,2-d]pyrimidine结构式
|
常用名 | 4-(4-{[4-(2-Chlorophenyl)piperazin-1-yl]carbonyl}piperidin-1-yl)[1]benzofuro[3,2-d]pyrimidine | 英文名 | 4-(4-{[4-(2-Chlorophenyl)piperazin-1-yl]carbonyl}piperidin-1-yl)[1]benzofuro[3,2-d]pyrimidine |
|---|---|---|---|---|
| CAS号 | 1112429-08-9 | 分子量 | 476.0 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C26H26ClN5O2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 4-(4-{[4-(2-Chlorophenyl)piperazin-1-yl]carbonyl}piperidin-1-yl)[1]benzofuro[3,2-d]pyrimidine |
|---|
| 分子式 | C26H26ClN5O2 |
|---|---|
| 分子量 | 476.0 |
| InChIKey | YCPUCSJMUDNGGG-UHFFFAOYSA-N |
| SMILES | C1CN(CCC1C(=O)N2CCN(CC2)C3=CC=CC=C3Cl)C4=NC=NC5=C4OC6=CC=CC=C65 |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|